NCT Number: NCT07122219
This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Edmonton Institution for Women, Edmonton, Alberta, Canada
Using a step-wedge design, we will conduct a Type 2 hybrid implementation trial to assess the extent to which PNEP uptake is improved over 24 months of observation using the Network for the Improvement of Addiction Treatment (NIATx) implementation strategy bundle. Nine prisons were non-randomly* allocated to one of three groups, with the groups receiving the intervention (i.e., NIATx) over 24 months at staggered time intervals (every 6 months). This will be followed by an additional 12 month post-intervention period, when sustainability will be assessed.
*Originally randomized; allocation was modified due to logistical constraints
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Network for the Improvement of Addiction Treatment (NIATx) model uses a bundle of implementation tools that include expert facilitation (coaching) and quality process improvement specifically for behavioural healthcare settings to improve access and retention in treatment.
Time frame: From start to end of intervention period (24 months)
Number of participants on the PNEP
Time frame: From start to end of intervention period (24 months)
Number of HIV and hepatitis C virus screenings/tests, diagnoses, and treatment initiations, among the total prison population
Time frame: From start to end of intervention period (24 months)
The number of people who inject drugs who access opioid agonist therapy among the total prison population
Contact information is provided by the study sponsor or research team.
McGill University Health Centre/Research Institute of the McGill University Health Centre
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02898987
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Belfort, France
View Trial DetailsNCT07170748
Bacterial Infections, Bacterial Infections and Mycoses
Abidjan, Côte d’Ivoire
View Trial DetailsNCT06766331
Bacterial Infections, Bacterial Infections and Mycoses
Northport, New York, United States
View Trial DetailsNCT05376371
Blood-Borne Infections, Chemically-Induced Disorders
Oregon, Wisconsin, United States
View Trial Details